ArticleThe pharmacogenomics journal2024

Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity.

Romain Larrue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.